These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 26880631)
21. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease. Liu L; Wan W; Xia S; Kalionis B; Li Y Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746 [TBL] [Abstract][Full Text] [Related]
22. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling. Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019 [TBL] [Abstract][Full Text] [Related]
23. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab. Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843 [TBL] [Abstract][Full Text] [Related]
24. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Rossini M; Gatti D; Adami S Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710 [TBL] [Abstract][Full Text] [Related]
25. Hyperthyroidism and Hypothyroidism in Male Mice and Their Effects on Bone Mass, Bone Turnover, and the Wnt Inhibitors Sclerostin and Dickkopf-1. Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Rauner M Endocrinology; 2015 Oct; 156(10):3517-27. PubMed ID: 26218891 [TBL] [Abstract][Full Text] [Related]
26. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation. Koppen A; Ait-Aissa R; Hopman S; Koster J; Haneveld F; Versteeg R; Valentijn LJ Cancer Lett; 2007 Oct; 256(2):218-28. PubMed ID: 17643814 [TBL] [Abstract][Full Text] [Related]
27. Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway. Knobloch J; Shaughnessy JD; Rüther U FASEB J; 2007 May; 21(7):1410-21. PubMed ID: 17283219 [TBL] [Abstract][Full Text] [Related]
31. [Wnt signaling and glucocorticoid-induced osteoporosis]. Ohnaka K Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847 [TBL] [Abstract][Full Text] [Related]
32. Bone mass is inversely proportional to Dkk1 levels in mice. MacDonald BT; Joiner DM; Oyserman SM; Sharma P; Goldstein SA; He X; Hauschka PV Bone; 2007 Sep; 41(3):331-9. PubMed ID: 17613296 [TBL] [Abstract][Full Text] [Related]
33. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Koay MA; Brown MA Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771 [TBL] [Abstract][Full Text] [Related]
34. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone]. Kobayashi T Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985 [TBL] [Abstract][Full Text] [Related]
35. Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure-activity relationships. Thysiadis S; Mpousis S; Avramidis N; Katsamakas S; Balomenos A; Remelli R; Efthimiopoulos S; Sarli V Bioorg Med Chem; 2016 Mar; 24(5):1014-22. PubMed ID: 26819000 [TBL] [Abstract][Full Text] [Related]
36. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613 [TBL] [Abstract][Full Text] [Related]
37. Comparison of serum Dkk1 (Dickkopf-1) and bone mineral density in patients on bisphosphonate treatment vs no treatment. Memon AR; Butler JS; O'Riordan MV; Guerin E; Dimitrov BD; Harty JA J Clin Densitom; 2013; 16(1):118-24. PubMed ID: 22959779 [TBL] [Abstract][Full Text] [Related]
38. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584 [TBL] [Abstract][Full Text] [Related]
39. The effects of dickkopf 1 on gene expression and Wnt signaling by melanocytes: mechanisms underlying its suppression of melanocyte function and proliferation. Yamaguchi Y; Passeron T; Watabe H; Yasumoto K; Rouzaud F; Hoashi T; Hearing VJ J Invest Dermatol; 2007 May; 127(5):1217-25. PubMed ID: 17159916 [TBL] [Abstract][Full Text] [Related]
40. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]